Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersTumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesMetastatic cancer stem cells: from the concept to therapeuticsResearch progress and prospects of markers for liver cancer stem cellsTurning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionNew Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor ImmunotherapyCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Involvement of inflammation and its related microRNAs in hepatocellular carcinomaStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerEMT, CTCs and CSCs in tumor relapse and drug-resistanceThe synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinomaTowards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer.Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections.Circulating tumor cells in the central and peripheral venous compartment - assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß.Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombusDetection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinomaShort-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to TreatmentPreoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling.Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinomaBy inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisGrowth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaDetection of circulating tumor cells by p75NTR expression in patients with esophageal cancerCancer stem cells in the development of liver cancerAptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
P2860
Q26741204-F81F8C5F-16F3-400D-9EEF-84C1C8FF7FF8Q26744100-3E1D0C5A-DB83-48AC-9958-8E428028AEF8Q26850739-B3B2C20A-C3B7-40DF-9808-80B7C1803CE5Q27022262-AE678D34-8ED8-4C9C-A30A-FAFDFB834237Q27692697-0135D6FB-3295-4EBC-9C88-9DD6FA89B207Q28066285-A7110AA8-407B-4CF3-BF51-BF7F4C6BB317Q28072045-9C14E8D2-19E0-460B-BA9E-B7978B70AE30Q28077340-FDD0BCCB-C9E8-447A-93AB-55B2CDCA7184Q28079138-1A1493A0-99E1-430E-9A4F-34F6BDAD00AFQ28079205-4EA4D4AA-2AA0-4BC4-A6EE-D33C87CE71DBQ28082935-22DA3C83-1B0A-4746-99C0-C681B7846DBAQ28538702-13518166-D71C-4AB9-9942-DA1BDEDD9F6CQ30445250-D0D54AAF-486B-402C-9AFE-AB2C6127FC98Q33626833-7C8CCAF3-3146-4287-A24D-ECBF2605F8CFQ33745977-4B07AA63-589C-435C-B5C1-BF2D6AF39BD4Q33820823-A776BAA9-0DDF-478F-8B76-DF0F047A88E4Q33837659-3E145613-4DD3-46B5-BC9E-53C54F9BB83FQ33952761-EE2D62C2-B444-442C-9CCC-E3E0E9D2984FQ34924005-CEA46668-89F5-49E8-8CED-F31D23F940C9Q34971918-1E4F2309-E29A-4E2E-810D-1ADAE8A31844Q35075280-BFB220C1-4E43-466E-871E-C48D2AEF48E7Q35144077-EC87558C-A8C9-412D-A038-F95529F99AA7Q35157131-1FA84DB3-1671-4C26-B84B-82D7C11CD01EQ35169325-3313E545-D72C-44F0-B4D3-59F172D60B0CQ35241955-9511C284-E700-4C4A-978B-AB8FB43E8ED7Q35440625-96B18B3E-6CBD-4902-9BFF-7A5571560244Q35552063-74D225B6-1E61-40F2-8597-D44125CAD4CDQ35640863-B7A46843-B63A-463B-A5EA-A275F5ECA2E4Q35745018-47F93CFA-BF38-444B-BECF-75DD78F0C842Q35764913-9101C2E8-8C8F-4D5B-B726-B12BF89D80BFQ35858695-70B47BAE-B4B7-4C91-8E9E-96B18B97BD62Q36019935-2FB0E320-5697-43A9-BE99-CF63A21FC1C5Q36083213-784F6A10-494E-473E-A189-D03C69D928E0Q36365682-DED7A6AC-0A72-4EEF-9015-4996D8B607CDQ36386499-A1DF246F-A7B5-4F15-9D02-E55E09174F6AQ36413730-0C2B803F-0851-46D6-A024-2BEF3CC6B13DQ36413954-7CFC237B-44D5-4FC2-9776-AE75831B28B0Q36600679-71FF51B4-26CF-4857-B2F6-2FA55358F779Q36793453-7570BAA3-7883-4447-9100-128ED0566D4AQ37202310-EB607BFE-0149-491F-979D-27483FF1EE08
P2860
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Circulating stem cell-like epi ...... noma after curative resection.
@en
Circulating stem cell-like epi ...... noma after curative resection.
@nl
type
label
Circulating stem cell-like epi ...... noma after curative resection.
@en
Circulating stem cell-like epi ...... noma after curative resection.
@nl
prefLabel
Circulating stem cell-like epi ...... noma after curative resection.
@en
Circulating stem cell-like epi ...... noma after curative resection.
@nl
P2093
P2860
P356
P1433
P1476
Circulating stem cell-like epi ...... noma after curative resection.
@en
P2093
Ruo-Yu Shi
Shuang-Jian Qiu
Xin-Rong Yang
Yun-Fan Sun
P2860
P304
P356
10.1002/HEP.26151
P407
P577
2013-03-04T00:00:00Z